NCT06145308 2026-04-02Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular TypingPeking Union Medical CollegePhase 2 Recruiting39 enrolled
NCT03942653 2025-12-31Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland CarcinomaBig Ten Cancer Research ConsortiumPhase 2 Recruiting20 enrolled